The Harvard Crimson4d
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs
The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech activities, ...
F. Hoffmann-La Roche Ltd: Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard's Enterprise Research Campus in Allston
The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in d ...
Business Wire8d
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Technology Activities, Innovation Programs, Initiatives, Partnership, Investments & Acquisition Network Map ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into ...
F. Hoffmann-La Roche Ltd: FDA accepts supplemental Biologics License Application for Roche's Gazyva/Gazyvaro for the treatment of lupus nephritis
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a complete renal response benefit1 The filing application is based on data from the phase ...
pharmaphorum2d
A history of Roche
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
Immuno-Oncology Market Is Predicted To Reach US$ 111.64 Billion By 2034, Expanding At A CAGR Of 16.5% Fact.MR
Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...
Medscape3d
Port System Cuts Injection Burden in Diabetic Eye Disease
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...